Augmedix, Inc.Augmedix, Inc.Augmedix, Inc.

Augmedix, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪44.88 M‬USD
−0.4263USD
‪−19.17 M‬USD
‪44.86 M‬USD
‪47.45 M‬
Beta (1Y)
0.67

About Augmedix, Inc.

CEO
Emmanuel Krakaris
Headquarters
San Francisco
Employees (FY)
‪1.43 K‬
Founded
2012
FIGI
BBG006674MJ1
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AUGX is 0.9166 USD — it has increased by 0.94% in the past 24 hours. Watch Augmedix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Augmedix, Inc. stocks are traded under the ticker AUGX.
AUGX stock has fallen by 8.34% compared to the previous week, the month change is a 9.68% rise, over the last year Augmedix, Inc. has showed a 80.58% decrease.
We've gathered analysts' opinions on Augmedix, Inc. future price: according to them, AUGX price has a max estimate of 13.40 USD and a min estimate of 1.50 USD. Watch AUGX chart and read a more detailed Augmedix, Inc. stock forecast: see what analysts think of Augmedix, Inc. and suggest that you do with its stocks.
AUGX reached its all-time high on Mar 31, 2021 with the price of 10.0000 USD, and its all-time low was 0.7300 USD and was reached on Jun 6, 2024. View more price dynamics on AUGX chart.
See other stocks reaching their highest and lowest prices.
AUGX stock is 3.78% volatile and has beta coefficient of 0.67. Track Augmedix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Augmedix, Inc. there?
Today Augmedix, Inc. has the market capitalization of ‪44.88 M‬, it has decreased by 10.56% over the last week.
Yes, you can track Augmedix, Inc. financials in yearly and quarterly reports right on TradingView.
Augmedix, Inc. is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AUGX earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.13 USD resulting in a 7.69% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Augmedix, Inc. earnings.
Augmedix, Inc. revenue for the last quarter amounts to ‪13.47 M‬ USD, despite the estimated figure of ‪13.36 M‬ USD. In the next quarter, revenue is expected to reach ‪13.64 M‬ USD.
AUGX net income for the last quarter is ‪−6.50 M‬ USD, while the quarter before that showed ‪−4.49 M‬ USD of net income which accounts for −44.71% change. Track more Augmedix, Inc. financial stats to get the full picture.
No, AUGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 13, 2024, the company has ‪1.43 K‬ employees. See our rating of the largest employees — is Augmedix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Augmedix, Inc. EBITDA is ‪−18.47 M‬ USD, and current EBITDA margin is −39.42%. See more stats in Augmedix, Inc. financial statements.
Like other stocks, AUGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Augmedix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Augmedix, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Augmedix, Inc. stock shows the sell signal. See more of Augmedix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.